Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Neoplasms 7Leukemia, Myeloid, Acute 7Lung Neoplasms 5Ovarian Neoplasms 4Fatigue 4Colorectal Neoplasms 4Pancreatic Neoplasms 3Lymphoma 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Multiple Myeloma 2Melanoma 2Leukemia 2Hematologic Neoplasms 2Glioma 2Genital Neoplasms, Female 2Esophageal Neoplasms 2Depression 2Weight Loss 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Counseling 3Surveys and Questionnaires 2Motivational Interviewing 2College Fraternities and Sororities 2Transportation 1Spermine Synthase 1Risk Factors 1Risk Assessment 1Riluzole 1Price Transparency 1Palliative Care 1Interviews as Topic 1House Calls 1Ethanol 1Educational Status 1Decision Support Techniques 1Cannabidiol 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Behavior × Palliative Care × Clear all
NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed
30 enrolled

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡